Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Gains from Investment Securities (2016 - 2025)

Bio-Techne has reported Gains from Investment Securities over the past 17 years, most recently at $900000.0 for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $900000.0 for Q4 2025, up 12.5% from a year ago — trailing twelve months through Dec 2025 was $900000.0 (up 12.5% YoY), and the annual figure for FY2025 was $1.8 million, up 56.48%.
  • Gains from Investment Securities for Q4 2025 was $900000.0 at Bio-Techne, roughly flat from $900000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for TECH hit a ceiling of $232.0 million in Q1 2023 and a floor of -$26.7 million in Q2 2022.
  • Median Gains from Investment Securities over the past 5 years was $2.8 million (2022), compared with a mean of $28.2 million.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 571.43% in 2021 and later surged 6723.53% in 2023.
  • Bio-Techne's Gains from Investment Securities stood at $25.0 million in 2021, then crashed by 90.8% to $2.3 million in 2022, then crashed by 43.48% to $1.3 million in 2023, then crashed by 38.46% to $800000.0 in 2024, then grew by 12.5% to $900000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $900000.0 (Q4 2025), $900000.0 (Q3 2025), and $30.6 million (Q2 2025) per Business Quant data.